BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32221923)

  • 1. Application of CRISPR/Cas9-Mediated Genome Editing in Leishmania.
    Zhang WW; Lypaczewski P; Matlashewski G
    Methods Mol Biol; 2020; 2116():199-224. PubMed ID: 32221923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized CRISPR-Cas9 Genome Editing for
    Zhang WW; Lypaczewski P; Matlashewski G
    mSphere; 2017; 2(1):. PubMed ID: 28124028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 Technology Applied to the Study of Proteins Involved in Calcium Signaling in Trypanosoma cruzi.
    Lander N; Chiurillo MA; Docampo R
    Methods Mol Biol; 2020; 2116():177-197. PubMed ID: 32221922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Leishmania Strains.
    Abdi Ghavidel A; Aghamiri S; Raee P; Mohammadi-Yeganeh S; Noori E; Bandehpour M; Kazemi B; Jajarmi V
    Acta Parasitol; 2024 Mar; 69(1):121-134. PubMed ID: 38127288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone.
    Vazquez N; Sanchez L; Marks R; Martinez E; Fanniel V; Lopez A; Salinas A; Flores I; Hirschmann J; Gilkerson R; Schuenzel E; Dearth R; Halaby R; Innis-Whitehouse W; Keniry M
    BMC Mol Biol; 2018 Mar; 19(1):3. PubMed ID: 29540148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
    Sollelis L; Ghorbal M; MacPherson CR; Martins RM; Kuk N; Crobu L; Bastien P; Scherf A; Lopez-Rubio JJ; Sterkers Y
    Cell Microbiol; 2015 Oct; 17(10):1405-12. PubMed ID: 25939677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and Efficient Gene Deletion by CRISPR/Cas9.
    Neldeborg S; Lin L; Stougaard M; Luo Y
    Methods Mol Biol; 2019; 1961():233-247. PubMed ID: 30912049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 14. LeishGEdit: A Method for Rapid Gene Knockout and Tagging Using CRISPR-Cas9.
    Beneke T; Gluenz E
    Methods Mol Biol; 2019; 1971():189-210. PubMed ID: 30980304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Homology-Mediated CRISPR/Cas9-Based Method for Genome Editing in Fission Yeast.
    Hayashi A; Tanaka K
    G3 (Bethesda); 2019 Apr; 9(4):1153-1163. PubMed ID: 30755408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
    Tang L; Gong M; Zhang P
    Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Microbial Modification Tools to Convert Lipids into Other Value-Added Products.
    Kumari P; Yusuf F; Gaur NA
    Methods Mol Biol; 2019; 1995():161-171. PubMed ID: 31148128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.
    Shen B; Brown K; Long S; Sibley LD
    Methods Mol Biol; 2017; 1498():79-103. PubMed ID: 27709570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing in Potato with CRISPR/Cas9.
    Nadakuduti SS; Starker CG; Voytas DF; Buell CR; Douches DS
    Methods Mol Biol; 2019; 1917():183-201. PubMed ID: 30610637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-Mediated Genome Editing for Huntington's Disease.
    Vachey G; Déglon N
    Methods Mol Biol; 2018; 1780():463-481. PubMed ID: 29856031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.